BLU — BELLUS Health Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.87bn
- $1.56bn
- $0.02m
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln
Deals of the day-Mergers and acquisitions
Bellus soars as GSK plans to buy drug developer for $2 bln
Brief: GSK To Acquire Bellus Health For $2 Bln
GSK to buy Canada's Bellus Health for $2 bln (updated)
GSK to buy Canada's Bellus Health for $2 bln
Brief: Bellus Health Announces Positive Results From Phase 1 Bioavailability Equivalence Study
Brief: Bellus Health Reports 2022 Financial Results
Bellus Health Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview
Bellus Health Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: BELLUS Health Reports Third Quarter 2022 Financial Results, Business Highlights
Brief: BELLUS Health To Present Clinical Data From Trial Of BLU-5937
Canada Stocks: TSX ends flat in volatile trade, gold stocks gain
Brief: Bellus Health Inc Files For Stock Shelf Size Not Disclosed - SEC Filing
Brief: Bellus Health Reports Second Quarter 2022 Financial Results And Business Highlights
Brief: Bellus Health Announces Pricing Of Us$153 Million Public Offering In Canada And The United States